Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


LOW-DOSE KETAMINE AS ADJUVANT TREATMENT TO MORPHINE IN NEUROPATHIC CANCER PAIN.


To see complete record on www.clinicaltrialsregister.eu, please visit this link

Id: 2012-001175-36

Organisation Name: Haukeland University hospital

Start Date: 2013-01-16

Completion Date: Ongoing

Brief Summary: To see whether the addition of low-dose ketamine to a subcutaneous morphine infusion improves analgesia in patients with refractory neuropathic cancer pain.

Country: Norway



Total execution time in seconds: 0.094851970672607